[go: up one dir, main page]

MX2010004017A - 5-cianotienopiridinas para el tratamiento de tumores. - Google Patents

5-cianotienopiridinas para el tratamiento de tumores.

Info

Publication number
MX2010004017A
MX2010004017A MX2010004017A MX2010004017A MX2010004017A MX 2010004017 A MX2010004017 A MX 2010004017A MX 2010004017 A MX2010004017 A MX 2010004017A MX 2010004017 A MX2010004017 A MX 2010004017A MX 2010004017 A MX2010004017 A MX 2010004017A
Authority
MX
Mexico
Prior art keywords
sup
thienopyridines
cyano
tumors
treatment
Prior art date
Application number
MX2010004017A
Other languages
English (en)
Inventor
Christiane Amendt
Harmut Greiner
Guenter Hoelzemann
Ulrich Graedler
Djordje Musil
Per Hillertz
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of MX2010004017A publication Critical patent/MX2010004017A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Las nuevas 5-ciano-tienopiridinas de la f?rmula I (ver f?rmula (I)) en donde R1, R2 y R3 tienen los significados indicados en la reivindicaci?n 1, son inhibidores de la quinasa del receptor TGF-beta, y se pueden emplear, por ejemplo, para el tratamiento de tumores.
MX2010004017A 2007-10-16 2008-09-19 5-cianotienopiridinas para el tratamiento de tumores. MX2010004017A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007049451A DE102007049451A1 (de) 2007-10-16 2007-10-16 5-Cyano-thienopyridine
PCT/EP2008/007888 WO2009049743A1 (de) 2007-10-16 2008-09-19 5-cyano-thienopyridine zur behandlung von tumoren

Publications (1)

Publication Number Publication Date
MX2010004017A true MX2010004017A (es) 2010-04-27

Family

ID=40262956

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010004017A MX2010004017A (es) 2007-10-16 2008-09-19 5-cianotienopiridinas para el tratamiento de tumores.

Country Status (16)

Country Link
US (1) US8202882B2 (es)
EP (1) EP2197886B1 (es)
JP (1) JP5480811B2 (es)
KR (1) KR20100076026A (es)
CN (1) CN101827851A (es)
AR (1) AR068872A1 (es)
AU (1) AU2008314245B2 (es)
BR (1) BRPI0818170A2 (es)
CA (1) CA2702551A1 (es)
DE (1) DE102007049451A1 (es)
EA (1) EA201000618A1 (es)
ES (1) ES2401936T3 (es)
IL (1) IL205137A0 (es)
MX (1) MX2010004017A (es)
WO (1) WO2009049743A1 (es)
ZA (1) ZA201003425B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7904970B2 (en) 2009-02-20 2011-03-15 J-Brem, LLC Headwear with features for holding eyeglasses
MX2012008550A (es) 2010-02-05 2012-09-07 Merck Patent Gmbh Derivados de hetaril-[1, 8]naftiridina.
AU2011217561B2 (en) 2010-02-22 2016-04-21 Merck Patent Gmbh Hetarylaminonaphthyridines
EA201491530A1 (ru) * 2012-03-20 2015-07-30 Серагон Фармасьютикалс, Инк. Модуляторы рецепторов эстрогенов и их применение
US9801863B2 (en) 2012-04-16 2017-10-31 Case Western Reserve University Inhibitors of short-chain dehydrogenase activity for modulating hematopoietic stem cells and hematopoiesis
EP2947084B8 (en) * 2013-01-18 2021-03-10 Guangzhou Maxinovel Pharmaceuticals Co. Five-and-six-membered heterocyclic compound, and preparation method, pharmaceutical composition and use thereof
US9789116B2 (en) * 2013-10-15 2017-10-17 Case Western Reserve University Compositions and methods of modulating short-chain dehydrogenase activity
HK1250636A1 (zh) 2015-03-08 2019-01-11 卡斯西部储备大学 用於治疗纤维症的短链脱氢酶活性的抑制剂
US11690847B2 (en) 2016-11-30 2023-07-04 Case Western Reserve University Combinations of 15-PGDH inhibitors with corticosteroids and/or TNF inhibitors and uses thereof
NZ796735A (en) 2017-02-06 2025-12-19 Univ Case Western Reserve Compositions and methods of modulating short-chain dehydrogenase activity
CN120463720A (zh) 2018-11-21 2025-08-12 卡斯西部储备大学 调节短链脱氢酶活性的组合物和方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747469A (en) 1991-03-06 1998-05-05 Board Of Regents, The University Of Texas System Methods and compositions comprising DNA damaging agents and p53
GB9904387D0 (en) 1999-02-25 1999-04-21 Pharmacia & Upjohn Spa Antitumour synergistic composition
WO2000061186A1 (en) 1999-04-08 2000-10-19 Arch Development Corporation Use of anti-vegf antibody to enhance radiation in cancer therapy
GB0323810D0 (en) 2003-10-10 2003-11-12 Cancer Rec Tech Ltd Pyridothiophene compounds
WO2005058315A1 (en) 2003-12-12 2005-06-30 Ribapharm, Inc. Novel heterocyclic compounds as ikk2 inhibitors with anti-hbv activity
DE102005009440A1 (de) * 2005-03-02 2006-09-07 Merck Patent Gmbh Thienopyridinderivate
DE102005024245A1 (de) 2005-05-27 2006-11-30 Merck Patent Gmbh Thienopyridine

Also Published As

Publication number Publication date
AR068872A1 (es) 2009-12-09
CA2702551A1 (en) 2009-04-23
EP2197886A1 (de) 2010-06-23
KR20100076026A (ko) 2010-07-05
ES2401936T3 (es) 2013-04-25
US8202882B2 (en) 2012-06-19
IL205137A0 (en) 2010-11-30
CN101827851A (zh) 2010-09-08
AU2008314245A1 (en) 2009-04-23
EA201000618A1 (ru) 2011-04-29
ZA201003425B (en) 2011-04-28
JP2011500610A (ja) 2011-01-06
AU2008314245B2 (en) 2013-07-18
BRPI0818170A2 (pt) 2017-05-16
DE102007049451A1 (de) 2009-04-23
JP5480811B2 (ja) 2014-04-23
US20100234369A1 (en) 2010-09-16
WO2009049743A1 (de) 2009-04-23
EP2197886B1 (de) 2012-12-26

Similar Documents

Publication Publication Date Title
MX2010004017A (es) 5-cianotienopiridinas para el tratamiento de tumores.
MX2009013077A (es) Derivados dde benzoxazolona.
MX2010003368A (es) Derivados de imidazol.
MX2009012708A (es) Derivados de piridazinona.
UA100540C2 (en) 2-benzylpyridazinone derivatives as met kinase inhibitors
MX2009010034A (es) Pirimidodiazepinas sustituidas utiles inhibidores de la plk1.
MY163477A (en) Pyrimidinyl-pyridazinone derivatives
MX2010003366A (es) Derivados de piperidina y piperazina para el tratamiento de tumores.
MX2009013341A (es) Derivados de 6-(pirrolopiridinil)-pirimidinil-2-amina.
MX2010007392A (es) Antagonistas de trpa1.
IL191832A (en) Pyridiazinone compounds and their use in the preparation of drugs for the treatment of tumors
SG178986A1 (en) 4-substituted pyridin-3-yl-carboxamide compounds and methods of use
MX2009012709A (es) Derivados de arileter-piridazinona.
WO2010000364A8 (de) Pyrrolopyridinyl-pyrimidin-2-yl-amin-derivate
PH12013502369A1 (en) Diazacarbazoles and methods of use
GEP20135785B (en) Pyrrolopyrimidine compounds as cdk inhibitors
MX2010007391A (es) Antagonistas de trpa1.
EA201000550A1 (ru) Производные тиазола
EA201100035A1 (ru) Производные тиазолилпиперидина
MX2012006822A (es) 1,7-diazacarbazoles y metodos de uso.
WO2009124653A3 (de) Thienopyrimidine
MX2011007165A (es) Derivados de piridazinona.
MX2008002104A (es) Derivados de 1-acildihidropirazol.
MX2008001538A (es) Aril piridinas y metodos para su uso.
IL198465A0 (en) Triazabenzo[e]azulene derivatives for the treatment of tumors

Legal Events

Date Code Title Description
FA Abandonment or withdrawal